Tarsus Pharmaceuticals Market Sentiment

Tarsus Pharmaceuticals Inc

TARSNASDAQ

Trade with Public

$74.05

-0.19-0.26%

At close: Sep 1, 5:00 PM EST

$74.05

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Tarsus Pharmaceuticals Market Sentiment

Market sentiment signals for Tarsus Pharmaceuticals (TARS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 14.2% short float

Options Flow— 1.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

10 analysts

Options Flow (P/C)

1.00

Balanced — Neutral

2 calls · 2 puts

Avg Consensus PT

$81

+9.0%

Highest Price Target

$100

+35.0%

Oppenheimer

Lowest Price Target

$51

-31.1%

Goldman Sachs

Short Interest

14.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 12, 2026	Oppenheimer	Francois Brisebois—	+35.0%	$97 → $100	Maintained	Outperform
Jul 31, 2026	Mizuho	Graig Suvannavejh—	+32.3%	$100 → $98	Maintained	Outperform
Jul 21, 2026	Guggenheim	Brad Canino—	+20.2%	$90 → $89	Maintained	Buy
Jul 9, 2026	HC Wainwright & Co.	Matthew Caufield—	+18.8%	$88 → $88	Maintained	Buy
May 4, 2026	HC Wainwright & Co.	Matthew Caufield—	+18.8%	$88 → $88	Maintained	Buy
Feb 25, 2026	Oppenheimer	Francois Brisebois—	+41.8%	$95 → $105	Maintained	Outperform
Feb 25, 2026	Guggenheim	Eddie Hickman—	+21.5%	$87 → $90	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	+35.0%	$100	Initiate	Overweight
Nov 20, 2025	Mizuho	Graig Suvannavejh—	+35.0%	$100	Initiate	Outperform
Nov 5, 2025	Guggenheim	Eddie Hickman—	+17.5%	$84 → $87	Maintained	Buy
Oct 20, 2025	HC Wainwright & Co.	Matthew Caufield—	+18.8%	$72 → $88	Maintained	Buy
May 27, 2025	HC Wainwright & Co.	Matthew Caufield—	-2.8%	$72	Assumes	Buy
May 5, 2025	Goldman Sachs	Andrea Tan—	-31.1%	$46 → $51	Maintained	Neutral
May 2, 2025	Guggenheim	Eddie Hickman—	+13.4%	$78 → $84	Maintained	Buy
Mar 6, 2025	Jefferies	Anthony Petrone—	-21.7%	$54 → $58	Maintained	Buy
Feb 26, 2025	Guggenheim	Eddie Hickman—	+5.3%	$75 → $78	Maintained	Buy
Feb 26, 2025	HC Wainwright & Co.	Oren Livnat—	-1.4%	$73 → $73	Maintained	Buy
Feb 26, 2025	Barclays	Balaji Prasad—	-19.0%	$62 → $60	Maintained	Overweight
Feb 24, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Feb 10, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Jan 27, 2025	Barclays	Balaji Prasad—	-16.3%	$60 → $62	Maintained	Overweight
Jan 22, 2025	Oppenheimer	Francois Brisebois—	-2.8%	$65 → $72	Maintained	Outperform
Nov 15, 2024	Goldman Sachs	Andrea Tan—	-44.6%	$36 → $41	Maintained	Neutral
Nov 14, 2024	Oppenheimer	Francois Brisebois—	-12.2%	$63 → $65	Maintained	Outperform
Aug 9, 2024	Oppenheimer	Francois Brisebois—	-14.9%	$61 → $63	Maintained	Outperform